Module 3 - Strategic case studies in practice

2 8 March 2019 EMA/CHMP/ICH/353369/2013 Committee for Human Medicinal Products

ICH guideline Q3D (R1) on elemental impurities

Step 5

Transmission to CHMP

26 April 2018

Adoption by CHMP

26 April 2018

Release for public consultation

26 April 2018

End of consultation on the Cadmium Inhalation PDE (deadline for comments)

26 July 2018

Final adoption by CHMP

28 March 2019

Official address Domenico Scarlattilaan 6 ● 1083 HS Amsterdam ● The Netherlands Address for visits and deliveries Refer to www.ema.europa.eu/how-to-find-us Send us a question Go to www.ema.europa.eu/contact Telephone +31 (0)88 781 6000

An agency of the European Union

© European Medicines Agency, 2019. Reproduction is authorised provided the source is acknowledged.